Literature DB >> 24374234

Regulation of myosin IIA and filamentous actin during insulin-stimulated glucose uptake in 3T3-L1 adipocytes.

Richard Stall1, Joseph Ramos1, F Kent Fulcher1, Yashomati M Patel2.   

Abstract

Insulin stimulated glucose uptake requires the colocalization of myosin IIA (MyoIIA) and the insulin-responsive glucose transporter 4 (GLUT4) at the plasma membrane for proper GLUT4 fusion. MyoIIA facilitates filamentous actin (F-actin) reorganization in various cell types. In adipocytes F-actin reorganization is required for insulin-stimulated glucose uptake. What is not known is whether MyoIIA interacts with F-actin to regulate insulin-induced GLUT4 fusion at the plasma membrane. To elucidate the relationship between MyoIIA and F-actin, we examined the colocalization of MyoIIA and F-actin at the plasma membrane upon insulin stimulation as well as the regulation of this interaction. Our findings demonstrated that MyoIIA and F-actin colocalized at the site of GLUT4 fusion with the plasma membrane upon insulin stimulation. Furthermore, inhibition of MyoII with blebbistatin impaired F-actin localization at the plasma membrane. Next we examined the regulatory role of calcium in MyoIIA-F-actin colocalization. Reduced calcium or calmodulin levels decreased colocalization of MyoIIA and F-actin at the plasma membrane. While calcium alone can translocate MyoIIA it did not stimulate F-actin accumulation at the plasma membrane. Taken together, we established that while MyoIIA activity is required for F-actin localization at the plasma membrane, it alone is insufficient to localize F-actin to the plasma membrane.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipocytes; Calcium; Filamentous actin (F-actin); Insulin-responsive glucose transporter (GLUT4); Myosin IIA

Mesh:

Substances:

Year:  2013        PMID: 24374234      PMCID: PMC3930059          DOI: 10.1016/j.yexcr.2013.12.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  40 in total

1.  A redistribution of actin and myosin IIA accompanies Ca(2+)-dependent insulin secretion.

Authors:  J R Wilson; R I Ludowyke; T J Biden
Journal:  FEBS Lett       Date:  2001-03-09       Impact factor: 4.124

2.  The role of Ca2+ in insulin-stimulated glucose transport in 3T3-L1 cells.

Authors:  J P Whitehead; J C Molero; S Clark; S Martin; G Meneilly; D E James
Journal:  J Biol Chem       Date:  2001-05-24       Impact factor: 5.157

3.  Differential localization of myosin II isoforms in resting and activated osteoclasts.

Authors:  I Krits; R B Wysolmerski; L S Holliday; B S Lee
Journal:  Calcif Tissue Int       Date:  2002-09-18       Impact factor: 4.333

4.  Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation.

Authors:  C Taha; Z Liu; J Jin; H Al-Hasani; N Sonenberg; A Klip
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

5.  Perinuclear localization and insulin responsiveness of GLUT4 requires cytoskeletal integrity in 3T3-L1 adipocytes.

Authors:  A Guilherme; M Emoto; J M Buxton; S Bose; R Sabini; W E Theurkauf; J Leszyk; M P Czech
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

6.  Recruitment of a myosin heavy chain kinase to actin-rich protrusions in Dictyostelium.

Authors:  P A Steimle; S Yumura; G P Côté; Q G Medley; M V Polyakov; B Leppert; T T Egelhoff
Journal:  Curr Biol       Date:  2001-05-01       Impact factor: 10.834

7.  The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes.

Authors:  Dorothy Sears Worrall; Jerrold M Olefsky
Journal:  Mol Endocrinol       Date:  2002-02

8.  Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling.

Authors:  M Kanzaki; J E Pessin
Journal:  J Biol Chem       Date:  2001-09-06       Impact factor: 5.157

9.  Myosin II is present in gastric parietal cells and required for lamellipodial dynamics associated with cell activation.

Authors:  Rihong Zhou; Charles Watson; Chuanhai Fu; Xuebiao Yao; John G Forte
Journal:  Am J Physiol Cell Physiol       Date:  2003-04-30       Impact factor: 4.249

10.  Myo1c binding to submembrane actin mediates insulin-induced tethering of GLUT4 vesicles.

Authors:  Shlomit Boguslavsky; Tim Chiu; Kevin P Foley; Cesar Osorio-Fuentealba; Costin N Antonescu; K Ulrich Bayer; Philip J Bilan; Amira Klip
Journal:  Mol Biol Cell       Date:  2012-08-23       Impact factor: 4.138

View more
  5 in total

1.  Rac-mediated actin remodeling and myosin II are involved in KATP channel trafficking in pancreatic β-cells.

Authors:  Young-Eun Han; Ajin Lim; Sun-Hyun Park; Sunghoe Chang; Suk-Ho Lee; Won-Kyung Ho
Journal:  Exp Mol Med       Date:  2015-10-16       Impact factor: 8.718

2.  Septin 7 reduces nonmuscle myosin IIA activity in the SNAP23 complex and hinders GLUT4 storage vesicle docking and fusion.

Authors:  Anita A Wasik; Vincent Dumont; Jukka Tienari; Tuula A Nyman; Christopher L Fogarty; Carol Forsblom; Markku Lehto; Eero Lehtonen; Per-Henrik Groop; Sanna Lehtonen
Journal:  Exp Cell Res       Date:  2016-12-20       Impact factor: 3.905

3.  MYH10 Governs Adipocyte Function and Adipogenesis through Its Interaction with GLUT4.

Authors:  Nadav Kislev; Lisa Mor-Yossef Moldovan; Rakefet Barak; Michael Egozi; Dafna Benayahu
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

4.  On-target action of anti-tropomyosin drugs regulates glucose metabolism.

Authors:  Anthony J Kee; Jayshan Chagan; Jeng Yie Chan; Nicole S Bryce; Christine A Lucas; Jun Zeng; Jeff Hook; Herbert Treutlein; D Ross Laybutt; Justine R Stehn; Peter W Gunning; Edna C Hardeman
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

5.  Functional expression of TRPM7 as a Ca2+ influx pathway in adipocytes.

Authors:  Hana Inoue; Masato Inazu; Masato Konishi; Utako Yokoyama
Journal:  Physiol Rep       Date:  2019-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.